LC-MS/MS METHOD FOR L-DOPA QUANTIFICATION IN DIFFERENT TISSUES OF VICIA FABA

por Pavón-Pérez,Jessy, Oviedo,Claudia A., Elso-Freudenberg,Mhartyn, Henríquez-Aedo,Karem, Aranda,Mario
Publicado 2019

PROTONATION EQUILIBRIA OF L-DOPA AND 1,10 PHENONTHROLINE IN PROPYLENE GLYCOL-WATER MIXTURES

por RAMA RAJU,B, SANTHEE DEVI,K V, PADMAJA,N, NAGESWARA RAO,G
Publicado 2011

Phytotherapy in treatment of Parkinson’s disease: a review

por Zahra Rabiei, Kamal Solati, Hossein Amini-Khoei
Publicado 2019

Personalized Medicine to Improve Treatment of Dopa-Responsive Dystonia—A Focus on Tyrosine Hydroxylase Deficiency

por Gyrid Nygaard, Peter D. Szigetvari, Ann Kari Grindheim, Peter Ruoff, Aurora Martinez, Jan Haavik, Rune Kleppe, Marte I. Flydal
Publicado 2021

The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Retraction]

por Hinz M, Stein A, Cole T
Publicado 2021

The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]

por Hinz M, Stein A, Cole T
Publicado 2020

Effects of Carbidopa Premedication on ¹⁸F-FDOPA PET Imaging of Glioma: A Multiparametric Analysis

por Marie Bros, Timothée Zaragori, Fabien Rech, Marie Blonski, Gabriela Hossu, Luc Taillandier, Pierre-Yves Marie, Antoine Verger
Publicado 2021

NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats

por Wu N, Song L, Yang X, Yuan W, Liu Z
Publicado 2013

PARK2 Patient Presenting with Dopa-Responsive Dystonia

por Fumihito Yoshii, Koji Aono, Ryuya Kumazawa, Wakoh Takahashi
Publicado 2021

Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]

por Hinz M, Stein A, Cole T
Publicado 2020

Adhesive Antimicrobial Peptides Containing 3,4-Dihydroxy-L-Phenylalanine Residues for Direct One-Step Surface Coating

por Young Eun Hwang, Seonghun Im, Hyun Kim, Jung-Hoon Sohn, Byung-Kwan Cho, Ju Hyun Cho, Bong Hyun Sung, Sun Chang Kim
Publicado 2021

Parkinson’s Disease-Associated Melanin Steal [Retraction]

por Hinz M, Stein A, Cole T
Publicado 2021

L-dopa-Dependent Effects of GLP-1R Agonists on the Survival of Dopaminergic Cells Transplanted into a Rat Model of Parkinson Disease

por Osama F. Elabi, Jeffrey S. Davies, Emma L. Lane
Publicado 2021

Association of Hepatitis C Virus Replication with the Catecholamine Biosynthetic Pathway

por George Mpekoulis, Vassilina Tsopela, Georgios Panos, Vasileiοs Siozos, Katerina I. Kalliampakou, Efseveia Frakolaki, Constantinos D. Sideris, Alice G. Vassiliou, Diamantis C. Sideris, Dido Vassilacopoulou, Niki Vassilaki
Publicado 2021

Long-term changes in short-interval intracortical facilitation modulate motor cortex plasticity and L-dopa-induced dyskinesia in Parkinson's disease

por Andrea Guerra, Francesco Asci, Alessandro Zampogna, Valentina D'Onofrio, Antonio Suppa, Giovanni Fabbrini, Alfredo Berardelli
Publicado 2022

Parkinson’s disease managing reversible neurodegeneration

por Hinz M, Stein A, Cole T, McDougall B, Westaway M
Publicado 2016

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]

por Hinz M, Stein A, Cole T, McDougall B, Westaway M
Publicado 2020

Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]

por Hinz M, Stein A, Cole T, McDougall B, Westaway M
Publicado 2020

Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]

por Hinz M, Stein A, Neff R, Weinberg R, Uncini T
Publicado 2020

Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Retraction]

por Hinz M, Stein A, Neff R, Weinberg R, Uncini T
Publicado 2020